Login / Signup
Rajat Shah
ORCID
Publication Activity (10 Years)
Years Active: 2021-2023
Publications (10 Years): 5
Top Topics
Phase Iii
Double Blind
Squamous Cell Carcinoma
Clinical Trial
Top Venues
Journal of dietary supplements
Journal of experimental pharmacology
Clinical pharmacology : advances and applications
Evidence-based complementary and alternative medicine : eCAM
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Shefali Thanawala
,
Rajat Shah
,
R Abiraamasundari
,
R Senthurselvi
,
Prabakaran Desomayanandam
Comparative Bioavailability and Benefits on Mental Functions of Novel Extended-Release Caffeine Capsules against Immediate-Release Caffeine Capsules: An Open-Label, Randomized, Cross-over, Single-Dose Two-Way Crossover Study.
Journal of dietary supplements
(2023)
Shefali Thanawala
,
Rajat Shah
,
R Abiraamasundari
,
R Senthurselvi
,
Prabakaran Desomayanandam
Comparative Bioavailability and Benefits on Mental Functions of Novel Extended-Release Caffeine Capsules against Immediate-Release Caffeine Capsules: An Open-Label, Randomized, Cross-over, Single-Dose Two-Way Crossover Study.
Journal of dietary supplements
(2023)
Alluri Venkata KrishnaRaju
,
Venkateswarlu Somepalli
,
Shefali Thanawala
,
Rajat Shah
Efficacy and Anti-Inflammatory Activity of Ashwagandha Sustained-Release Formulation on Depression and Anxiety Induced by Chronic Unpredictable Stress: in vivo and in vitro Studies.
Journal of experimental pharmacology
15 (2023)
Shefali Thanawala
,
Rajat Shah
,
Vasu Karlapudi
,
Prabakaran Desomayanandam
,
Arun Bhuvanendran
Efficacy and Safety of TurmXTRA® 60N in Delayed Onset Muscle Soreness in Healthy, Recreationally Active Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial.
Evidence-based complementary and alternative medicine : eCAM
2022 (2022)
Shefali Thanawala
,
Rajat Shah
,
Venkateswarlu Somepalli
,
Venkata Krishnaraju Alluri
,
Prabakaran Desomayanandam
,
Arun Bhuvanendran
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Assessing Efficacy and Safety of a Novel Low-Dose Turmeric Extract Formulation in Healthy Adults with Chronic Knee Pain.
Clinical pharmacology : advances and applications
13 (2021)